CIK 0001896212
- Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 873272543
- Phone
- +1 646-491-9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
Page 1 of 3 · 58 filings